Search

Author/Creator Harrington, K J

1. 1047PDPembrolizumab for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of treatment options from the phase III KEYNOTE-040 trial. (23rd October 2018)

Authors:
Le Tourneau, C; Cohen, E E W; Harrington, K J; Dinis, J; Licitra, L; Ahn, M -J; Soria, A; Machiels, J-P; Mach, N; Mehra, R; Burtness, B; Zhang, P; Cheng, J; Swaby, R; Soulières, D
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1849PATR inhibition with radiation creates an inflammatory tumour microenvironment. (23rd October 2018)

Authors:
Dillon, M T; Bergerhoff, K; Pedersen, M; Whittock, H; Patin, E; Smith, H; Paget, J; Patel, R; Bozhanova, G; Foo, S; Campbell, J; Ragulan, C; Fontana, E; Wilkins, A; Sadanandam, A; Melcher, A; McLaughlin, M; Harrington, K J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. LBA8_PRKEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). (23rd October 2018)

Authors:
Burtness, B; Harrington, K J; Greil, R; Soulières, D; Tahara, M; De Castro, G; Psyrri, A; Baste Rotllan, N; Neupane, P C; Bratland, Å; Fuereder, T; Hughes, B G M; Mesia, R; Ngamphaiboon, N; Rordorf, T; Wan Ishak, W Z; Roy, A; Cheng, J; Jin, F; Rischin, D
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗